50 subscribers
Offline dengan aplikasi Player FM !
Vascepa gains event-reduction nod; diabetes ups ischemic risks
Manage episode 248500595 series 2355282
Vascepa approved for cardiovascular risk reduction The FDA’s decision on cutting events in high-risk patients was based primarily on the REDUCE-IT trial.
ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding Novel oral anticoagulants may be preferred over warfarin in patients with diabetes and AFib.
HHS drug importation proposals aim to address high costs Trump administration drops key health care proposal on day of impeachment vote.
End ‘therapeutic nihilism’ in care of older diabetic patients, says expert ‘It’s not hyperglycemia that’s killing people; it’s heart disease and renal disease.’
* * *
For more MDedge Podcasts, go to mdedge.com/podcasts
Email the show: podcasts@mdedge.com
Interact with us on Twitter: @MDedgeTweets
87 episode
Manage episode 248500595 series 2355282
Vascepa approved for cardiovascular risk reduction The FDA’s decision on cutting events in high-risk patients was based primarily on the REDUCE-IT trial.
ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding Novel oral anticoagulants may be preferred over warfarin in patients with diabetes and AFib.
HHS drug importation proposals aim to address high costs Trump administration drops key health care proposal on day of impeachment vote.
End ‘therapeutic nihilism’ in care of older diabetic patients, says expert ‘It’s not hyperglycemia that’s killing people; it’s heart disease and renal disease.’
* * *
For more MDedge Podcasts, go to mdedge.com/podcasts
Email the show: podcasts@mdedge.com
Interact with us on Twitter: @MDedgeTweets
87 episode
Semua episode
×
1 Top stories from the American Heart Association scientific sessions 7:42

1 Vascepa gains event-reduction nod; diabetes ups ischemic risks 8:16

1 Post-STEMI events less likely in women; bariatric surgery may lower stroke risk 7:27

1 New trick for old drug; Vascepa cost effective for CV reduction 7:12

1 ISCHEMIA trial, DAPA-HF, and valsartan recall: AHA Special 32:06

1 Long-awaited ISCHEMIA results to change practice, DAPA-HF elevates dapagliflozin for HFrEF 8:42

1 Pot heightens stroke, arrhythmia risks; keeping low LDL and BP slashes lifetime heart risk 8:02

1 How risk factors in childhood translate to CV outcomes in adulthood 8:33

1 Driving while defibrillating; hypertension holds greater risk in black patients 7:51

1 AFib hits Native Americans hard; TAVR shown durable, safe after 5 years 7:38

1 Practice changing prevention data from ESC 2019 Part II 42:06

1 Statins tied to skin, soft tissue infections; new Card Talk episode 41:38

1 Troponin protocol rapidly rules out MI; hidden risk of moderate aortic stenosis 8:51

1 Sun sets on longer DAPT after PCI; inactivity boosts post-MI risk 8:52
Selamat datang di Player FM!
Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.